science
plus
.abes.fr
|
explorer
À propos de :
Wailoo A.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Wailoo A.
Wailoo Allan J.
personal mailbox
a.j.wailoo@sheffield.ac.uk
familyName
Wailoo
Given name
A.
Allan
Allan J.
is
relates
of
http://hub.abes.fr/bmj/periodical/heartjnl/2009/volume_96/issue_9/B35772F80C882F84E053120B220A0936/authorship/1
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_328/issue_7439/B36D7AEB99F814DEE053120B220A6B62/authorship/1
http://hub.abes.fr/bmj/periodical/heart/2011/volume_97/issue_2/B35772F810502F84E053120B220A0936/authorship/1
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7465/B36DBB0061FF649BE053120B220A93E8/authorship/1
http://hub.abes.fr/oup/periodical/brheum/2008/volume_47/issue_10/101093rheumatologyken326/authorship/1
http://hub.abes.fr/oup/periodical/brheum/2010/volume_49/issue_12/101093rheumatologykeq169/authorship/3
http://hub.abes.fr/oup/periodical/brheum/2008/volume_47/issue_2/101093rheumatologykem294/authorship/1
is
Author
of
The effectiveness of anti-TNF-α therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis
Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance
Comment on: Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance: reply
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
